Fixed and flexible doses of tavapadon significantly improved motor function compared with placebo in patients with Parkinson’s disease, according to a pair of phase 3 trials presented at the American ...

Chronic constipation can be an early sign of Parkinson's disease, appearing even years before the onset of motor symptoms, and is a common non-motor symptom associated with the condition. The ...

World Parkinson’s Day is observed on April 11 every year to raise awareness about the neurological condition and its effects ...

World Parkinson's Day highlights the challenges of Parkinson's disease, while encouraging global awareness, support, and ongoing research for better treatment options.

World Parkinson's Disease Day is observed to raise awareness about this progressive neurological disorder that affects ...

Parkinson’s disease is often described as bleak strokes, shaky hands, stiff limbs, a slow decline. But can movement be the ...

Novant Health says it’s one of the first healthcare systems in the country treating Parkinson’s patients differently with a ...

A tiny protein at the center of Parkinson’s disease also plays a surprising role in melanoma, a dangerous skin cancer. New ...

A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as ...

Both fixed and flexible doses of investigational tavapadon met their primary endpoint in phase III trials of early ...

TEMPO-2 is part of a broader clinical development program evaluating tavapadon as a potential monotherapy or adjunctive treatment in Parkinson’s disease. While TEMPO-1 and TEMPO-3 have concluded, a ...

King's College Hospital Dubai launches Foslevodopa treatment, transforming Parkinson's care for the youngest patient in MENA.